Supreme Court to hold human-gene patent hearing today

The Supreme Court is set to hear oral arguments today in a case that could determine whether companies have the right to patent human genes. The specific dispute involves Myriad Genetics' patents on two genes linked to breast and ovarian cancer. Critics of gene patents said that patents should not be allowed on parts of the human body and that patents impede medical progress. Myriad Genetics and its supporters, including BIO, meanwhile, said that a ruling against gene patents could force companies to stop investing in genetics research, to the detriment of patients and also the economy.

View Full Article in:

New York Times (tiered subscription model), The · Reuters · Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC